Back to KROS
AMERIPRISE FINANCIAL INC → KROS
AMERIPRISE FINANCIAL INC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
7
Latest value
$727K
Q3 2026
Peak value
$2.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.5M |
| Q1 2026 | $1.1M |
| Q1 2026 | $4K |
| Q1 2026 | $1.1M |
| Q1 2026 | $4K |
| Q2 2026 | $1.1M |
| Q3 2026 | $727K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $727K | 63.8K | — | — |
| Q2 2026 | $1.1M | 101.3K | — | — |
| Q1 2026 | $4K | 325 | — | — |
| Q1 2026 | $1.1M | 102.2K | — | — |
| Q1 2026 | $4K | 325 | — | — |
| Q1 2026 | $1.1M | 102.2K | — | — |
| Q4 2025 | $2.5M | 122.8K | — | — |